| Financial Year |
March 31 2023 |
| Monetary Funds |
491,386,252.91 |
| Held-for-trading Financial Assets |
1,877,960,528.89 |
| Notes Receivable |
-- |
| Accounts Receivable |
403,778,553.00 |
| Advances to Suppliers |
51,356,991.08 |
| Other Receivables |
62,675,672.01 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
896,005,822.72 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
62,474,380.66 |
| Total Current Assets |
3,861,194,622.59 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
281,497,284.64 |
| Investment Properties |
66,713,475.98 |
| Fixed Assetes |
1,682,284,418.73 |
| Under-construction Projects |
327,328,811.67 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
225,835,352.11 |
| R&D expenses |
-- |
| Goodwill |
15,508,178.31 |
| Long-Term Deferred and Prepaid Expenses |
4,462,699.41 |
| Deferred Income Tax Assets |
84,481,052.88 |
| Other Non-Current Assets |
24,303,063.50 |
| Sub-Total of Non-Current Assets |
3,031,630,117.86 |
| Total Assets |
6,892,824,740.45 |
| Short-Term Loans |
150,000,000.00 |
| Trading Financial liabilities |
-- |
| Notes Payable |
121,450,000.00 |
| Accounts Payable |
1,182,711,177.35 |
| Accounts Received In Advance |
-- |
| Employee Compensation Payable |
169,800,793.07 |
| Taxes Payable |
109,370,053.26 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
315,117,048.56 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
8,062,139.38 |
| Other Current Liabilities |
46,304,553.15 |
| Sub-Total of Current Liabilities |
2,459,004,635.18 |
| Long-term Loans |
-- |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
30,000,000.00 |
| Special Payable |
-- |
| Estimatied Liabilities |
-- |
| Deferred Income Tax Liabilities |
57,965,432.76 |
| Other Non-Current Liabilities |
49,113,332.73 |
| Sub-Total of Non-Current Liabilities |
268,795,499.76 |
| Total Liabilities |
2,727,800,134.94 |
| Paid-In Capital(Or Share Stock) |
879,184,048.00 |
| Capital Surplus |
294,555,166.45 |
| Surplus Reserve |
210,332,981.41 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
2,779,485,922.94 |
| Minority Stockholder's Interest |
776,065.77 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
4,164,248,539.74 |
| Owner's Equity（Stockholder's Equity） |
4,165,024,605.51 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
6,892,824,740.45 |
